High speed liquid chromatography for in-process control of rifabutin

Analytica Chimica Acta

Volumn 531, Issue 1, 2005, Pages 105-110

  Blanco Gomis, Domingo ^a   Sánchez Núñez, Noé ^a   Andrés García, Elena ^a   Arias Abrodo, Pilar ^a   Bayod Jasanada, Miguel ^b   Gutiérrez Álvarez, Ma Dolores ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b Asturpharma SA   (Spain)

Author keywords

High speed HPLC; In process control; Rifabutin

Indexed keywords

COLUMN CHROMATOGRAPHY; LIGHT ABSORPTION; PH EFFECTS; PROCESS CONTROL; SYNTHESIS (CHEMICAL); ULTRAVIOLET DETECTORS;

HIGH SPEED LIQUID CHROMATOGRAPHY; PRECURSORS; ULTRAVIOLET ABSORBANCE;

LIQUID CHROMATOGRAPHY;

RIFABUTIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT ABSORPTION; PH MEASUREMENT; PHASE SEPARATION; PRIORITY JOURNAL; SEPARATION TECHNIQUE; SYNTHESIS; VALIDATION PROCESS;

EID: 13844255267     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2004.09.083     Document Type: Article

References (25)

1. S.D. Nightingale, D.W. Cameron, F.M. Gordin, P.M. Sullam, D.L. Cohn, R.E. Chaisson, L.J. Eron, P.D. Sparti, B. Bihari, D.L. Kaufman, J.J. Stern, D.D. Pearce, W.G. Weinberg, A. LaMarca, and F.P. Siegal N. Engl. J. Med. 329 1993 828
2. S.D. Shafran, J. Singer, D.P. Zarowny, P. Phillips, I. Salit, S.L. Walmsley, I.W. Fong, M.J. Gill, A.R. Rachlis, R.G. Lalonde, M.M. Fanning, and C.M. Tsoukas N. Engl. J. Med. 335 1996 377
3. J. McCrea, D. Wyss, J. Stone, A. Carides, S. Kusma, C. Kleinbloesem, Y. AlHamdan, K. Yeh, and P. Deutsch Clin. Pharmacol. Ther. 61 1997 152
4. C.K. Finch, C.R. Chrisman, A.M. Baciewicz, and T.F. Self Arch. Int. Med. 162 2002 985
5. B.L. Heifets, M.D. Iseman, and J.P. Lindholm Am. Rev. Respir. Dis. 137 1988 711
6. B.L. Heifets, J.P. Lindholm, and M.D. Iseman Am. Rev. Respir. Dis. 137 1988 719
7. C.A. Benson, P.L. Williams, J.S. Currier, F. Holland, and J. McKinsey Clin. Infect. Dis. 37 2003 1234
8. F.M. Hamzeh, C. Benson, J. Gerber, and C. Flexner Clin. Pharmacol. Ther. 73 2003 159
9. W.K. Kraft, J.B. McCrea, G.A. Winchell, A. Carides, and S.A. Waldman J. Clin. Pharmacol. 44 2004 305
10. R.C. Lewis, N.Z. Hatfield, and P.K. Narang Pharm. Res. 8 1991 1434
11. Y.Y. Lau, G.D. Hanson, and B.J. Carel J. Chromatogr. B 676 1996 125
12. H. Bartels, and R. Bartels J. Chromatogr. B 686 1996 235
13. C.B. Trapnell, C. Jamis-Dow, R.W. Klecker, and J.M. Collins Antimicrob. Agents Chemother. 41 1997 924
14. I. Utkin, T. Koudriakova, T. Thompson, C. Cottrell, E. Iatsimirskaia, J. Barry, P. Vouros, and N. Gerber Drug Metab. Dispos. 25 1997 963
15. A. Cato, J. Cavanaugh, H. Shi, A. Hsu, J. Leonard, and R. Granneman Clin. Pharmacol. Ther. 63 1998 414
16. G. Gatti, C.R. De Pascalis, F. Miletich, R. Casazza, and D. Bassetti J. Chromatogr. B 728 1999 233
17. K. Gallicano, Y. Khaliq, G. Carignan, A. Tseng, S. Walmsley, and W. Cameron Clin. Pharmacol. Ther. 70 2001 149
18. R.E. Polk, D.F. Brophy, D.S. Israel, R. Patron, B.M. Sadler, G.E. Chittick, W.T. Symonds, Y. Lou, D. Kristoff, and D.S. Stein Antimicrob. Agents Chemother. 45 2001 502
19. United States Pharmacopeia, XXVII Rev., NF XXII, United States Pharmacopeial Convection, Inc., Rockville, 2004, p. 1647.
20. Real Farmacopea Española, 2nd ed., Suplemento 2.1, Ministerio de Sanidad y Consumo, Madrid, 2002, p. 3186.
21. D.V. McCalley J. Chromatogr. A 965 2002 51
22. CPMP/ICH/381/95, Note for Guidance on Validation of Analytical Methods: Definitions and Terminology, ICH Topic Q2A, Step 5, CPMP Adopted November 1994.
23. CPMP/ICH/281/95, Note for Guidance on Validation of Analytical Procedures: Methodology, ICH Topic Q2B, Step 4, CPMP Adopted December 1996.
24. J.L. DiCesare, M.W. Dong, and J.R. Grant Chromatographia 15 1982 595
25. M.C. Cels, S.G. Fora, M.P. Forn, J.S. Roca, L.V. Pla, Validación de métodos analíticos, Monografía de la Asociación Española de Farmacéuticos de la Industria, Sección Catalana, 1989.